aa
  • Search
  • Advanced Search

Perspectives

October 1, 2025


Preserving Critical Thinking in the Age of Large Language Models: The Paradox of Cognitive Load and Efficiency
Sangzin Ahn
Korean J Med. 2025;100(5):197-200.
Rapid advancements in large language models (LLMs) have fundamentally transformed research practices across academic disciplines, with considerable adoption rates among researchers. While empirical studies have demonstrated the substantial positive effects...

Perspectives

October 1, 2025


Present and Future of Cardiovascular Diseases in Korea: Prevention, Management, and Policy Recommendations
JuMee Wang, Hyun-Jae Kang, Eun Joo Cho, et al.
Korean J Med. 2025;100(5):201-212.

This study examined the current state of cardiovascular diseases (CVDs) in South Korea, highlighting their increasing prevalence due to rapid aging and lifestyle changes. It also identified key issues in...

What's new?

October 1, 2025


Recent Advances in Imaging Analysis for Interstitial Lung Disease
Ju Hyun Oh, Jin Woo Song
Korean J Med. 2025;100(5):225-233.
Interstitial lung disease (ILD) encompasses a heterogeneous group of pulmonary disorders with variable etiologies, clinical courses, and prognoses. Recent advances in imaging analysis, particularly automated quantification and artificial intelligence-based technologies,...

In-depth review

October 1, 2025


Patent Foramen Ovale Closure for Secondary Stroke Prevention
Hyue Mee Kim
Korean J Med. 2025;100(5):234-240.
Patent foramen ovale (PFO) is a common congenital cardiac anomaly that may serve as a conduit for paradoxical embolism, potentially leading to ischemic stroke. Randomized controlled trials have demonstrated that...

Original Article

October 1, 2025


Efficacy of Radiotherapy in Combination with Immune Checkpoint Blockade for Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
Yunjeong Lee, Minkyung Park, Eun Sun Jang, et al.
Korean J Med. 2025;100(5):252-262.
Background/Aims: Hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is associated with poor prognosis and low response rates to standard atezolizumab plus bevacizumab therapy (atezo/bev). This study aimed to...
Current Issue
Volume 100(5); Oct 2025
Volume100 No. 5

Korean Journal
of Medicine

Print ISSN: 1738-9364
Online ISSN: 2289-0769

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2025 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next
Close layer
prev next